Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — December 2020

Planlagt Fastgjort Låst Flyttet Genmab
1.1k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • Helge_LarsenPI-redaktørH Offline
    Helge_LarsenPI-redaktørH Offline
    Helge_LarsenPI-redaktør
    wrote on sidst redigeret af
    #408

    God morgen. 🙂

    1 Reply Last reply
    0
    • Helge_LarsenPI-redaktørH Offline
      Helge_LarsenPI-redaktørH Offline
      Helge_LarsenPI-redaktør
      wrote on sidst redigeret af
      #409

      Tirsdagens danske avisuddrag med
      nedlukning, hjælpepakker og C25https://www.proinvestor.com/investornyt/670160/tirsdagens-danske-avisuddrag-med-nedlukning-hjaelpepakker-og-c25

      1 Reply Last reply
      0
      • B Offline
        B Offline
        bibob
        wrote on sidst redigeret af
        #410

        OncLive. : Dr. Voorhees on updated Griffin results. https://www.onclive.com/view/dr-voorhees-on-updated-results-of-the-griffin-trial-in-multiple-myeloma?utm_source=sfmc&utm_medium=email&utm_campaign=12-7-20_KIT-20-OGD0768_OncLiveSS_GLOBAL ASH Conference Coverage eNews_Yescarta&eKey=amFuYm9ydXAxOTc4QGdtYWlsLmNvbQ==

        1 Reply Last reply
        0
        • B Offline
          B Offline
          bibob
          wrote on sidst redigeret af
          #411

          Dara sc. https://www.onclive.com/view/subcutaneous-daratumumab-combo-improves-pfs-in-rrmm?utm_source=sfmc&utm_medium=email&utm_campaign=12-7-20_KIT-20-OGD0768_OncLiveSS_GLOBAL ASH Conference Coverage eNews_Yescarta&eKey=amFuYm9ydXAxOTc4QGdtYWlsLmNvbQ==

          1 Reply Last reply
          0
          • B Offline
            B Offline
            bibob
            wrote on sidst redigeret af
            #412

            OncLive Dara combo. https://www.onclive.com/view/daratumumab-combo-improved-response-rates-for-patients-with-transplant-eligible-newly-diagnosed-multiple-myeloma?utm_source=sfmc&utm_medium=email&utm_campaign=12-7-20_KIT-20-OGD0768_OncLiveSS_GLOBAL ASH Conference Coverage eNews_Yescarta&eKey=amFuYm9ydXAxOTc4QGdtYWlsLmNvbQ==

            1 Reply Last reply
            0
            • B Offline
              B Offline
              bibob
              wrote on sidst redigeret af
              #413

              OncLive. Dara quadruplet. https://www.onclive.com/view/daratumumab-quadruplet-improves-hematologic-cr-rates-in-al-amyloidosis?utm_source=sfmc&utm_medium=email&utm_campaign=12-7-20_KIT-20-OGD0768_OncLiveSS_GLOBAL ASH Conference Coverage eNews_Yescarta&eKey=amFuYm9ydXAxOTc4QGdtYWlsLmNvbQ==

              1 Reply Last reply
              0
              • S Offline
                S Offline
                Sukkeralf
                wrote on sidst redigeret af
                #414

                Endpoint news: BCMA bawl: https://endpts.com/ash20-saw-a-bcma-brawl-whos-still-standing-and-who-got-knocked-out-for-good/

                1 Reply Last reply
                0
                • Legolas23L Offline
                  Legolas23L Offline
                  Legolas23
                  wrote on sidst redigeret af
                  #415

                  Kan du give et kort sum-op @Sukkeralf. Det kræver medlemskab at læse artiklen.

                  1 Reply Last reply
                  0
                  • E Offline
                    E Offline
                    E_L
                    wrote on sidst redigeret af
                    #416

                    "I think broadly now, that we’ve seen whenever we add daratumumab to the standard of care, whatever that may be, we seem to see a significant improvement in progression-free survival and improving depth of response,” he said. https://www.hcplive.com/view/daratumumab-pomalidomide-relapsed-refractory-multiple-myeloma

                    1 Reply Last reply
                    0
                    • S Offline
                      S Offline
                      Sukkeralf
                      wrote on sidst redigeret af
                      #417

                      Legolas ikke så meget nyt - artiklen mener nok at JNJ/Legends CAR-T er i førertrøjen omend de døjer med lidt neurotox. Regenron og JNJs BaAbs kommer vel ind som nummer to. Amgens BsAbs lider begge. BCMA ADC har for lav responsrate og AEs, hvor specielt ocular tox er et problem. Så ingen direkte vinder endnu....

                      1 Reply Last reply
                      0
                      • SolsenS Offline
                        SolsenS Offline
                        Solsen
                        wrote on sidst redigeret af
                        #418

                        Jeg har læst et sted, at Regenerons BCMA er bedre på safety end JNJs, men har ikke haft tid til at studere det nærmere.

                        1 Reply Last reply
                        0
                        • Legolas23L Offline
                          Legolas23L Offline
                          Legolas23
                          wrote on sidst redigeret af
                          #419

                          Takker 🙂

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #420

                            has anyone been able to see the Tahamtan Ahmadi talk & Q&A?

                            1 Reply Last reply
                            0
                            • G Offline
                              G Offline
                              GeorgeBest
                              wrote on sidst redigeret af
                              #421

                              No, I think it is only for people registered for ASH

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #422

                                yes, but i was hoping someone here had some contacts and saw it regardless...

                                1 Reply Last reply
                                0
                                • S Offline
                                  S Offline
                                  Sukkeralf
                                  wrote on sidst redigeret af
                                  #423

                                  E L I guess we will have more or less the same talk tonight

                                  1 Reply Last reply
                                  0
                                  • E Offline
                                    E Offline
                                    E_L
                                    wrote on sidst redigeret af
                                    #424

                                    probably, only, i imagine on the talk yesterday the questions would be from doctors, this evening from analysts -that might give a different perspective , if you know what i mean.

                                    1 Reply Last reply
                                    0
                                    • E Offline
                                      E Offline
                                      E_L
                                      wrote on sidst redigeret af
                                      #425

                                      talking about analysts, i was a bit surprised that Sydbank had not yet included anything on epco "Han har endnu ikke har indregnet de nye midler som eksempelvis epicoritamab i sine egne modeller, men siger at de også kommer med i beregningerne i takt med at flere data bliver offentliggjort" https://www.euroinvestor.dk/nyheder/sydbank-saerdeles-positive-data-fra-genmabs-nye-studie

                                      1 Reply Last reply
                                      0
                                      • E Offline
                                        E Offline
                                        E_L
                                        wrote on sidst redigeret af
                                        #426

                                        Ola Landgren, M.D.
                                        @DrOlaLandgren

                                        Daratumumab + KRd & Daratumumab + VRd = 2 most effective combos for newly diagnosed #myeloma in 2020/2021

                                        1 Reply Last reply
                                        0
                                        • E Offline
                                          E Offline
                                          E_L
                                          wrote on sidst redigeret af
                                          #427

                                          Camidanlumab https://twitter.com/YucaiWangMD/status/1336127652860751873

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger